NCT02552966View on ClinicalTrials.gov

Assessing the Impacts of a UESAD on Laryngeal Symptoms and Salivary Pepsin

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2018

Conditions
Laryngopharyngeal Reflux
Interventions
DEVICE

UESAD

Device designed to provide modest cricoid pressure to reduce reflux

All Listed Sponsors
collaborator

Somna Therapeutics, L.L.C.

INDUSTRY

lead

Northwestern University

OTHER

NCT02552966 - Assessing the Impacts of a UESAD on Laryngeal Symptoms and Salivary Pepsin | Biotech Hunter | Biotech Hunter